MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulato...

Full description

Saved in:
Bibliographic Details
Main Authors TRAN, Joe Anh, ZHOU, Jinglan, KHATUYA, Haripada, HADIDA RUAH, Sara Sabina, PIERRE, Fabrice Jean Denis, MILLER, Mark Thomas, GROOTENHUIS, Peter Diederik Jan, McCARTNEY, Jason, ISHIHARA, Yoshihiro, ABELA, Alexander Russell, CLEMENS, Jeremy J
Format Patent
LanguageEnglish
Published 05.10.2023
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
Bibliography:Application Number: US202217861567